Achilles Therapeutics Plc (ACHL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Operating Expenses | 17,799 | 14,299 | 19,514 | 19,096 | 18,092 |
| Operating Income | -17,799 | -14,299 | -19,514 | -19,096 | -18,092 |
| Other Income | 1,427 | 2,002 | 1,389 | 2,389 | 1,212 |
| Pre-tax Income | -16,372 | -12,297 | -18,125 | -16,707 | -16,880 |
| Income Tax | 8 | -23 | 505 | -24 | -34 |
| Net Income Continuous | -16,380 | -12,274 | -18,630 | -16,683 | -16,846 |
| Net Income | $-16,380 | $-12,274 | $-18,630 | $-16,683 | $-16,846 |
| EPS Basic Total Ops | -0.41 | -0.30 | -0.46 | -0.42 | -0.42 |
| EPS Basic Continuous Ops | -0.41 | -0.30 | -0.46 | -0.42 | -0.42 |
| EPS Diluted Total Ops | -0.41 | -0.30 | -0.46 | -0.42 | -0.42 |
| EPS Diluted Continuous Ops | -0.41 | -0.30 | -0.46 | -0.42 | -0.42 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.30 | -0.46 | -0.42 | -0.42 |
| EBITDA(a) | $-16,622 | $-13,119 | $-18,366 | $-17,892 | $-16,839 |